Exploratory associations of composite inflammatory-immune markers with 28-day and 1-year all-cause mortality in patients with sepsis: a retrospective cohort study

Aims Inflammation and immune dysregulation are central to sepsis pathobiology, but the prognostic value of a broad panel of composite inflammatory-immune indices remains incompletely defined. We evaluated the associations of 18 composite inflammatory-immune markers with 28-day and 1-year all-cause mortality in sepsis patients. Methods This single-center retrospective cohort study included 396 adult patients admitted to the intensive care unit (ICU) with sepsis. Eighteen inflammatory-immune indices were calculated from blood tests obtained within the first 24 h after ICU admission. Per-1-standard deviation (SD) multivariable Cox models were used to evaluate each marker’s association with 28-day and 1-year all-cause mortality. Subgroup analyses were performed by age (<75 vs. ≥75 years), sex, and sepsis-associated acute kidney injury status, with multiplicative interaction terms. Restricted cubic spline (RCS) analyses were used to assess nonlinearity. Results Among 396 patients, 174 (43.9%) died within 28 days and 230 (58.1%) died within 1 year. In the primary per-1-SD multivariable Cox analyses, higher C-reactive protein-to-lymphocyte ratio (CLR) and platelet-to-lymphocyte ratio (PLR) were associated with higher 28-day mortality (CLR: HR 1.313, 95% CI 1.145–1.505; P<0.001; PLR: HR 1.253, 95% CI 1.114–1.410; P<0.001) and 1-year mortality (CLR: HR 1.258, 95% CI 1.104–1.435; P<0.001; PLR: HR 1.193, 95% CI 1.071–1.329; P = 0.001). Higher lymphocyte-to-HDL-C ratio (LHR) was inversely associated with both endpoints (28-day: HR 0.759, 95% CI 0.626–0.920; P = 0.005; 1-year: HR 0.819, 95% CI 0.703–0.954; P = 0.010). Other markers showed endpoint-dependent or otherwise variable associations. Most formal interaction tests did not indicate heterogeneity by age, sex, or sepsis-associated acute kidney injury (SA-AKI) status; nominal interactions were observed for pan-immune-inflammation value with age for both endpoints and with SA-AKI status for 1-year mortality. RCS analyses showed nonlinear associations of log 10 -transformed PLR and CLR with both endpoints and an approximately linear inverse association of log 10 -transformed LHR with 28-day mortality. Conclusions Higher CLR and PLR and lower LHR were independently associated with both short- and long-term mortality in patients with sepsis. However, the findings were derived from a single-center retrospective cohort without independent validation and do not establish clinical prediction utility. Further multicenter studies are required to validate these markers before they can be considered for clinical risk stratification.

Authors

Institutions

Publication Details

Journal
Frontiers in Endocrinology
Published
2026-10-28
DOI
https://doi.org/10.3389/fendo.2026.1946659
Primary Topic
Sepsis Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Exploratory associations of composite inflammatory-immune markers with 28-day and 1-year all-cause mortality in patients with sepsis: a retrospective cohort study

Kexin Wen, Jiakai Wang, 皮晓红, Quansheng Du et al.
5 links
Frontiers in Endocrinology
Sepsis Diagnosis and Treatment
article

Exploratory associations of composite inflammatory-immune markers with 28-day and 1-year all-cause mortality in patients with sepsis: a retrospective cohort study

Kexin Wen, Jiakai Wang, 皮晓红, Quansheng Du, Kaitian Yao, Lei Li, Yaqi Wang, Chenxin Zhang
article en

Abstract

Aims Inflammation and immune dysregulation are central to sepsis pathobiology, but the prognostic value of a broad panel of composite inflammatory-immune indices remains incompletely defined. We evaluated the associations of 18 composite inflammatory-immune markers with 28-day and 1-year all-cause mortality in sepsis patients. Methods This single-center retrospective cohort study included 396 adult patients admitted to the intensive care unit (ICU) with sepsis. Eighteen inflammatory-immune indices were calculated from blood tests obtained within the first 24 h after ICU admission. Per-1-standard deviation (SD) multivariable Cox models were used to evaluate each marker’s association with 28-day and 1-year all-cause mortality. Subgroup analyses were performed by age (<75 vs. ≥75 years), sex, and sepsis-associated acute kidney injury status, with multiplicative interaction terms. Restricted cubic spline (RCS) analyses were used to assess nonlinearity. Results Among 396 patients, 174 (43.9%) died within 28 days and 230 (58.1%) died within 1 year. In the primary per-1-SD multivariable Cox analyses, higher C-reactive protein-to-lymphocyte ratio (CLR) and platelet-to-lymphocyte ratio (PLR) were associated with higher 28-day mortality (CLR: HR 1.313, 95% CI 1.145–1.505; P<0.001; PLR: HR 1.253, 95% CI 1.114–1.410; P<0.001) and 1-year mortality (CLR: HR 1.258, 95% CI 1.104–1.435; P<0.001; PLR: HR 1.193, 95% CI 1.071–1.329; P = 0.001). Higher lymphocyte-to-HDL-C ratio (LHR) was inversely associated with both endpoints (28-day: HR 0.759, 95% CI 0.626–0.920; P = 0.005; 1-year: HR 0.819, 95% CI 0.703–0.954; P = 0.010). Other markers showed endpoint-dependent or otherwise variable associations. Most formal interaction tests did not indicate heterogeneity by age, sex, or sepsis-associated acute kidney injury (SA-AKI) status; nominal interactions were observed for pan-immune-inflammation value with age for both endpoints and with SA-AKI status for 1-year mortality. RCS analyses showed nonlinear associations of log 10 -transformed PLR and CLR with both endpoints and an approximately linear inverse association of log 10 -transformed LHR with 28-day mortality. Conclusions Higher CLR and PLR and lower LHR were independently associated with both short- and long-term mortality in patients with sepsis. However, the findings were derived from a single-center retrospective cohort without independent validation and do not establish clinical prediction utility. Further multicenter studies are required to validate these markers before they can be considered for clinical risk stratification.

Frontiers in EndocrinologyVol. 17
Hebei Medical University (CN), Hebei North University (CN), Hebei General Hospital (CN)
Good health and well-being
Openalex Percentile: Top 12%
Sepsis Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon